Lilly, Jaguar Land Rover, Viacom: Intellectual Property

Eli Lilly & Co. and AstraZeneca Plc won’t have an easier time gaining more of the market for blood thinners dominated by Bristol-Myers Squibb Co.’s Plavix after the drug lost U.S. patent protection yesterday.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.